Table 2.

Results of clinician survey. SACT, systemic anti-cancer therapy

Clinician survey Likert scale questions (n = 15)
During the initial utilisation of telemedicine due to COVID-19, I felt fully equipped to carry out teleclinics
Strongly disagree   Disagree   Neither agree nor disagree   Agree   Strongly agree	0 (0.0%) 4 (26.7%) 4 (26.7%) 6 (40.0%) 1 (6.7%)
Telemedicine clinics have added to department workload
Strongly disagree   Disagree   Neither agree nor disagree   Agree   Strongly agree	0 (0.0%) 7 (46.7%) 4 (26.7%) 4 (26.7%) 0 (0.0%)
Telemedicine clinics result in similar outcomes as face-to-face clinics for the majority of patients
Strongly disagree   Disagree   Neither agree nor disagree   Agree   Strongly agree	0 (0.0%) 4 (26.7%) 0 (0.0%) 11 (73.3%) 0 (0.0%)
Telemedicine should have a place in routine oncology care following the resolution of the COVID19 pandemic
Strongly disagree   Disagree   Neither agree nor disagree   Agree   Strongly agree	0 (0.0%) 0 (0.0%) 0 (0.0%) 11 (73.3%) 4 (26.7%)
My opinion of telemedicine has improved since using it during COVID19
Strongly disagree   Disagree   Neither agree nor disagree   Agree   Strongly agree	0 (0.0%) 0 (0.0%) 2 (13.3%) 11 (73.3%) 2 (13.3%)
The inability to perform physical examination in telemedicine clinics is a significant limiting factor for a majority appointments
Strongly disagree   Disagree   Neither agree nor disagree   Agree   Strongly agree	0 (0.0%) 7 (46.7%) 5 (33.3%) 3 (20.0%) 0 (0.0%)
Telemedicine appointments should be held at the same time as corresponding face-to-face clinics
Strongly disagree   Disagree   Neither agree nor disagree   Agree   Strongly agree	0 (0.0%) 3 (20.0%) 4 (26.7%) 7 (46.7%) 1 (6.7%)
The current administrative infrastructure for clinics (e.g. booking appointments, outpatient bloods/scans, prescriptions) is capable of dealing with teleclinics efficiently
Strongly disagree   Disagree   Neither agree nor disagree   Agree   Strongly agree	1 (6.7%) 7 (46.7%) 2 (13.3%) 5 (33.3%) 0 (0.0%)
The following types of oncology clinic appointments are suitable for telemedicine:
New diagnosis
Strongly disagree     Disagree     Neither agree nor disagree     Agree     Strongly agree	13 (86.7%) 2 (13.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Surveillance
Strongly disagree     Disagree     Neither agree nor disagree     Agree     Strongly agree	0 (0.0%) 1 (6.7%) 1 (6.7%) 4 (26.7%) 9 (60.0%)
Consent to new treatment
Strongly disagree     Disagree     Neither agree nor disagree     Agree     Strongly agree	4 (26.7%) 7 (46.7%) 2 (13.3%) 2 (13.3%) 0 (0.0%)
Stable disease/continuation of established treatment
Strongly disagree     Disagree     Neither agree nor disagree     Agree     Strongly agree	0 (0.0%) 1 (6.7%) 0 (0.0%) 7 (46.7%) 7 (46.7%)
Progressive
Strongly disagree     Disagree     Neither agree nor disagree     Agree     Strongly agree	10 (66.7%) 5 (33.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
End-of-life/symptomatic care
Strongly disagree     Disagree     Neither agree nor disagree     Agree     Strongly agree	3 (20.0%) 5 (33.3%) 4 (26.7%) 3 (20.0%) 0 (0.0%)